Skip to main content

Further to his response to WPQ 56052 (2025), which disclosed that Pharmac entered into an NDA incurring legal expenditure across multiple months, on what dates did legal discussions or negotiations concerning this NDA begin and conclude? and 4 other questions

Answered 5 questions (2026)
Questions published
Reply lodged
Bookmark

Asked by

Ayesha Verrall

List MP · Labour Party

Questions

  • 4968

    Further to his response to WPQ 56052 (2025), which disclosed that Pharmac entered into an NDA incurring legal expenditure across multiple months, on what dates did legal discussions or negotiations concerning this NDA begin and conclude?

  • 4969

    Further to his response to WPQ 56052 (2025), which identified legal expenditure connected to an NDA, did Pharmac engage any external investigators, mediators, advisers, or legal representatives in relation to the matter covered by the NDA, and what were the costs for each?

  • 4970

    Further to his response to WPQ 56052 (2025), which reported legal expenditure associated with an NDA, were any settlement, severance, ex-gratia, or compensation payments made as part of the matter to which the NDA relates, and if so, what were the amounts?

  • 4977

    Further to his response to WPQ 56052 (2025), which disclosed that Pharmac entered into one NDA since 27 November 2023, was the party entering into the NDA with Pharmac an employee, contractor, supplier, or another type of individual or organisation?

  • 4978

    Further to his response to WPQ 56052 (2025), which confirmed that Pharmac entered into a single non-disclosure agreement since 27 November 2023, for what category of matter (employment, contractual, dispute resolution, or other) was that NDA used?

Answered by

Hon David Seymour

Member for Epsom · ACT Party · Associate Minister of Health

Answer

I am advised by Pharmac that it has legal duties with respect to agreements it signs. To strike an appropriate balance between those duties and Pharmac's reporting duties to Parliament, Pharmac provided relevant information in response to Select Committee’s questions. I refer the Member to those responses.